(Q39933308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Jens Wagenblast

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mehran Baghi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Christoph Arnoldner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Wolfgang Gstöttner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hanns Ackermann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Angelika May

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Markus Hambek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Rainald Knecht

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

387-393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-008-0477-0

15 January 2020

exact match

0 references

cites work

Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab

1 reference

12 December 2020

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

1 reference

12 December 2020

Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib

1 reference

12 December 2020

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

12 December 2020

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

1 reference

12 December 2020

The role of cetuximab in the treatment of squamous cell cancer of the head and neck

1 reference

12 December 2020

Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines

1 reference

12 December 2020

PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis

1 reference

12 December 2020

Putting the rap on Akt.

1 reference

12 December 2020

Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.

1 reference

12 December 2020

EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus

1 reference

12 December 2020

Biological significance of c-erbB family oncogenes in head and neck cancer

1 reference

12 December 2020

Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib.

1 reference

12 December 2020

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody

1 reference

12 December 2020

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.

1 reference

12 December 2020

Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines

1 reference

12 December 2020

Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials

1 reference

12 December 2020

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells

1 reference

12 December 2020

Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy

1 reference

12 December 2020

Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling

1 reference

12 December 2020

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.

1 reference

12 December 2020

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

1 reference

12 December 2020

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.

1 reference

12 December 2020

Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives

1 reference

12 December 2020

Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa

1 reference

12 December 2020

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

1 reference

12 December 2020

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer

1 reference

12 December 2020

10.1007/S00432-008-0477-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18830627%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference